Home › Burkitt Lymphoma › Colorado › Denver
Burkitt Lymphoma clinical trials in Denver, CO
6 studies for Burkitt Lymphoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
- CBCI, Colorado Blood Cancer Institute, Denver
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Colorado Children's Hospital, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
RecruitingPhase 1/2
- Sarah Cannon - Colorado Blood Cancer Institute, Denver
Burkitt Lymphoma trials in other cities
- Houston, TX21 studies
- Philadelphia, PA16 studies
- Milwaukee, WI16 studies
- Chicago, IL15 studies
- New York City, NY13 studies
- Cincinnati, OH13 studies
- Atlanta, GA12 studies
- Aurora, CO11 studies
- Seattle, WA11 studies
- Durham, NC10 studies
- Kansas City, MO10 studies
- Boston, MA10 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer29 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma27 studies
- Colorectal Cancer23 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.